Offer - Urjas Oil for just ₹ 1
PMX 1 Million IU Injection, a prescription drug, is manufactured in various forms such as Injection. Bacterial Infections are some of its major therapeutic uses. The alternative uses of PMX 1 Million IU Injection have also been explained below.
Medical history of the patient along with age and gender determines the dosage of PMX 1 Million IU Injection. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, PMX 1 Million IU Injection can also lead to other problems, which have been listed below. These side effects of PMX 1 Million IU Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, PMX 1 Million IU Injection's effect is Unknown during pregnancy and Unknown for lactating mothers. It is important to know if PMX 1 Million IU Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the PMX 1 Million IU Injection related warnings section.
PMX 1 Million IU Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid PMX 1 Million IU Injection in conditions like Kidney Disease. Other contraindications of PMX 1 Million IU Injection have been discussed in the sections ahead.
Besides this, PMX 1 Million IU Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that PMX 1 Million IU Injection is safe while driving, and is is addictive in nature.
PMX 1 Million IU Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
Is the use of PMX 1 Million IU Injection safe for pregnant women?
The effects of PMX on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of PMX 1 Million IU Injection safe during breastfeeding?
In the absence of any scientific study about the side effects of PMX in breastfeeding women, information on safety of PMX is unavailable.
What is the effect of PMX 1 Million IU Injection on the Kidneys?
Very few cases of side effects of PMX on kidney have been reported.
What is the effect of PMX 1 Million IU Injection on the Liver?
PMX is not harmful for the liver.
What is the effect of PMX 1 Million IU Injection on the Heart?
PMX is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take PMX 1 Million IU Injection unless your doctor advises you to do so -
Is this PMX 1 Million IU Injection habit forming or addictive?
PMX 1 Million IU Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking PMX 1 Million IU Injection since it will not make you feel sleepy.
Is it safe?
Yes, but take PMX 1 Million IU Injection only as per medical advice.
Is it able to treat mental disorders?
No, the use of PMX 1 Million IU Injection in mental disorders is not effective.
Interaction between Food and PMX 1 Million IU Injection
Taking PMX 1 Million IU Injection with food does not cause any problems.
Interaction between Alcohol and PMX 1 Million IU Injection
Information about the interaction of PMX 1 Million IU Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 759
